Ever Bilena’s Blackwater Women Drops A Sweet New Fragrance Line

From fruity gummies to elegant macarons, Blackwater Women’s new body sprays are a treat for every personality and occasion. #BWWomen #EverOrganics #ForeverBeauty #BetterThanBasic #EverBilena #YouFirst

328 Barangays Get Funding For Establishment Of Child Development Centers

Makatutulong ang bagong pondo sa 328 barangays sa pagbuo ng Child Development Centers, siguradong makikinabang ang mga bata sa maagang pag-aaral.

Early Childhood Education In Philippines To Get A Boost From PHP1 Billion Investment

Ang pondo ng gobyerno na PHP 1 bilyon para sa maagang edukasyon ay isang tagumpay para sa mga batang Pilipino sa mga underserved na komunidad.

More Baguio Folks Engage In Urban Agriculture For Food Sustainability

Ang proyekto ng agrikultura sa Baguio ay nagbibigay ng mga oportunidad sa mga kabataan at nagtataguyod ng pag-unlad sa lokal na sektor ng agrikultura.

Chinese Vax Maker Eyes Investments In PH

A Chinese pharmaceutical firm plans to invest in the Philippines.
By The Philippine Post

Chinese Vax Maker Eyes Investments In PH

3
3

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The Board of Investments (BOI) said Tuesday the agency met with Chinese global pharmaceutical firm Yisheng Biopharma Co. Ltd. to discuss the company’s investment plans in the Philippines.

Yisheng chairman Zhang Yi led the business delegation to Manila as the group also met with possible local partners here.

The Chinese pharmaceutical firm is engaged in the development and commercialization of biotherapeutics for cancers and infectious diseases through its novel PIKA immunomodulation technology.

The firm is operating in China, Singapore, and the United States.

“In the meeting, Chairman Yi and the Yisheng team shared that the company is preparing to initiate Phase III [of its] global multi-center clinical trial for its PIKA rabies vaccine, and Phase II-III combined trials for its PIKA COV-19 vaccine,” BOI said in a statement.

BOI Executive Director for Investment Promotions Evariste Cagatan said Yisheng’s investment plans in the Philippines are very timely as the BOI is collaborating with the Department of Health and the Department of Science and Technology for a vaccine self-reliance program by building the country’s vaccine production capability.

The government is also eyeing to start the vaccine self-reliance program with the manufacturing of coronavirus disease 2019 vaccines.

BOI Executive for Industry Development Service Ma. Corazon Halili-Dichosa added that Yisheng may also look into establishing a manufacturing facility in the country by partnering with local firms or with the government through the National Development Company.

“Yisheng can start its operation with the fill-and-finish business arrangement and eventually start formulation and expand its activities in other pharmaceutical manufacturing value chains – which the company acknowledged as a possible investment consideration,” BOI added. (PNA)